MedTrace Logo

An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)

NCT01775644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3003

Last updated 2021-12-02

No results posted yet for this study

Summary

This observational multicenter study will evaluate the differences in progression-free survival defined in specific subgroups of participants with metastatic colorectal cancer receiving bevacizumab (Avastin). Further, safety and efficacy in daily routine will be assessed.

Conditions

Interventions

DRUG

Bevacizumab

Administration of treatment will be as used in normal daily routine under local labeling.

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-14
Primary Completion
2019-05-10
Completion
2019-05-10
FDA Drug
Yes

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01775644 on ClinicalTrials.gov